McRae Capital Management’s Pfizer PFE Stock Holding History

McRae Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$613K	Hold	25,451	–	–	0.12%	63
2026 Q1	$715K	Sell	25,451 -2,500	-9%	-$66.6K	0.15%	62
2025 Q4	$696K	Sell	27,951 -1,379	-5%	-$34.8K	0.14%	53
2025 Q3	$747K	Sell	29,330 -3,500	-11%	-$86.4K	0.15%	54
2025 Q2	$796K	Sell	32,830 -300	-0.9%	-$7K	0.16%	51
2025 Q1	$840K	Sell	33,130 -72	-0.2%	-$1.88K	0.18%	52
2024 Q4	$881K	Buy	33,202 +72	+0.2%	+$1.95K	0.17%	47
2024 Q3	$959K	Sell	33,130 -6,150	-16%	-$179K	0.19%	46
2024 Q2	$1.1M	Sell	39,280 -2,700	-6%	-$74.3K	0.25%	41
2024 Q1	$1.16M	Hold	41,980	–	–	0.26%	42
2023 Q4	$1.21M	Hold	41,980	–	–	0.3%	41
2023 Q3	$1.39M	Hold	41,980	–	–	0.41%	33
2023 Q2	$1.54M	Buy	41,980 +300	+0.7%	+$11.7K	0.44%	33
2023 Q1	$1.7M	Sell	41,680 -500	-1%	-$21.6K	0.49%	33
2022 Q4	$2.16M	Sell	42,180 -1,400	-3%	-$67.1K	0.63%	33
2022 Q3	$1.91M	Buy	43,580 +26	+0.1%	+$1.26K	0.58%	33
2022 Q2	$2.28M	Buy	43,554 +1,028	+2%	+$52.4K	0.62%	36
2022 Q1	$2.2M	Buy	42,526 +1,407	+3%	+$73K	0.5%	37
2021 Q4	$2.43M	Hold	41,119	–	–	0.51%	36
2021 Q3	$1.77M	Sell	41,119 -160	-0.4%	-$7.09K	0.39%	38
2021 Q2	$1.62M	Hold	41,279	–	–	0.37%	39
2021 Q1	$1.5M	Buy	41,279 +143	+0.3%	+$5.08K	0.37%	38
2020 Q4	$1.51M	Buy	41,136 +29,647	+258%	+$1.09M	0.43%	37
2020 Q3	$400K	Sell	11,489 -1,897	-14%	-$66.5K	0.13%	63
2020 Q2	$415K	Hold	13,386	–	–	0.16%	60
2020 Q1	$415K	Sell	13,386 -3,357	-20%	-$114K	0.2%	54
2019 Q4	$622K	Hold	16,743	–	–	0.23%	52
2019 Q3	$571K	Buy	16,743 +37	+0.2%	+$1.34K	0.22%	51
2019 Q2	$687K	Sell	16,706 -315	-2%	-$12.5K	0.27%	45
2019 Q1	$686K	Sell	17,021 -3,821	-18%	-$153K	0.29%	50
2018 Q4	$863K	Sell	20,842 -316	-1%	-$13.1K	0.44%	35
2018 Q3	$885K	Sell	21,158 -66,148	-76%	-$2.55M	0.38%	37
2018 Q2	$3M	Buy	87,306 +66,336	+316%	+$2.27M	1.26%	28
2018 Q1	$706K	Sell	20,970 -56,673	-73%	-$1.95M	0.32%	42
2017 Q4	$2.67M	Buy	77,643 +67,144	+640%	+$2.29M	1.13%	25
2017 Q3	$356K	Sell	10,499 -490	-4%	-$15.7K	0.15%	68
2017 Q2	$350K	Sell	10,989 -389	-3%	-$12.3K	0.14%	71
2017 Q1	$369K	Sell	11,378 -1,897	-14%	-$59.8K	0.15%	64
2016 Q4	$409K	Sell	13,275 -301	-2%	-$9.19K	0.18%	62
2016 Q3	$436K	Buy	13,576 +301	+2%	+$10.1K	0.2%	59
2016 Q2	$443K	Buy	13,275 +1,952	+17%	+$62.3K	0.2%	55
2016 Q1	$318K	Buy	11,323 +1,427	+14%	+$40.8K	0.14%	69
2015 Q4	$303K	Hold	9,896	–	–	0.15%	61
2015 Q3	$295K	Buy	9,896 +490	+5%	+$15.7K	0.15%	60
2015 Q2	$299K	Hold	9,406	–	–	0.14%	58
2015 Q1	$310K	Sell	9,406 -948	-9%	-$30.1K	0.14%	58
2014 Q4	$306K	Hold	10,354	–	–	0.14%	62
2014 Q3	$290K	Hold	10,354	–	–	0.14%	62
2014 Q2	$292K	Sell	10,354 -264	-2%	-$7.53K	0.14%	63
2014 Q1	$324K	Hold	10,618	–	–	0.16%	57
2013 Q4	$309K	Sell	10,618 -211	-2%	-$6.14K	0.16%	57
2013 Q3	$295K	Buy	+10,829	New	+$295K	0.16%	55

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

McRae Capital Management's PFE Position: Q2 2026 in Review

McRae Capital Management held its Pfizer (PFE) position steady in Q2 2026 at 25,451 shares worth $613K. The position accounts for 0.12% of the portfolio, ranked #63.

McRae Capital Management first reported a position in PFE in Q3 2013 and has held it in 52 quarters since. The position peaked at $3M in Q2 2018. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

McRae Capital Management held 25,451 shares of Pfizer worth $613K as of Q2 2026.
McRae Capital Management left its Pfizer share count unchanged in Q2 2026.
Pfizer made up 0.12% of McRae Capital Management's portfolio in Q2 2026, its #63 holding.
McRae Capital Management first reported a position in Pfizer in Q3 2013 and has held it in 52 quarters since.
McRae Capital Management's Pfizer position peaked at $3M in Q2 2018.
2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on McRae Capital Management's 13F filing for Q2 2026, filed 17 Jul 2026.